［1］Dispenzieri A，Kyle RA，Lacy MQ，et al.POEMS syndrome：Definitions and long-term outcome［J］.Blood，2003，101（7）：2496-2506.
［2］ZHU Weiguo,WANG Yu,ZENG Xuejun,et al.A clinical analysis of 32 cases of POEMS syndrome［J］.Chin J Intern Med,2006,45(2):108-111.［朱卫国，王玉，增学军，等.POEMS综合征32例临床分析［J］.中华内科杂志，2006，45(2)：108-111.］
［3］Dispenzieri A.POEMS syndrome：2017 update on diagnosis，risk stratification，and management［J］.Am J Hematol，2017，92(8)：814-829.
［4］Dispenzieri A.POEMS syndrome［J］.Hematology，2007，21(6)：285-299.
［5］Jian L，Dao-bin Z.New advanced in the diagnosis and treatment of POEMS syndrome［J］.Bri J Haemato，2013，161(9)：303-315.
［6］Kourelis TV，Buadi FK，Kumar SK，et al.Long-term outcome of patients with POEMS syndrome：An update of the Mayo Clinic experience［J］.Am J Hematol，2016，91(6)：585-589.
［7］D' Souza A，Lacy M，Gertz M，et al.Long-term outcomes after autologous stem cell transplantation for patients witn POEMS syndrome(osteosclerotic myeloma)：A single-center experience［J］.Blood，2012，120(7)：56-62.
［8］Blade J，Cibeira MT，Rosinol L.Bortezomib：Avaluable new antineoplastic strategy in multiple myeloma［J］.Acta Oncol，2005，44(5)：440-448.
［9］He H，Fu W，Du J，et al.Successful treatment of newly diagnosed POEMS syndrome with reduced-dose bortezomib based regimen［J］.Br J Haematol，2018，181(1)：122-151.
［10］Tang X，Shi X，Sun A，et al.Successful bortezomib-based treatment in POEMS syndrome［J］.Eur J Haematol，2009，83(6)：609-610.
［11］Ohguchi H，Ohba R，Onishi Y，et al.Successful treatment with bortezomib and thalidomide for POEMS syndrome［J］.Ann Hematol，2011，90(9)：1113-1114.
［12］Li Linghao,Zhang Ri,Tang Xiaowen,et al.A case of POEMS syndrome treated with bortezomib based chemotherapy combined with hematopoietic stem cell transplantation［J］.Chin J Hematol,2011,32(11):733.
［13］Sobas MA，Alonso Vence N，Diaz Arias J，et al.Efficacy of bortezomib in refractory form of multicentric Castleman disease associated to poems syndrome(MCD-POEMS variant)［J］.Ann Hematol，2010，89(2)：217-219.
［14］Kaygusuz I，Tezcan H，Cetiner M，et al.Bortezomib：a new therapeutic option for POEMS syndrome［J］.Eur J Haematol，2010，84(2)：175-177.
［15］Warsame R，Kohut IE，Dispenzieri A.Successful use of cyclophosphamide，bortezomib，and dexamethasone to treat a case of relapsed POEMS［J］.Eur J Haematol，2012，88(6)：549-550.
［16］Wang X，Ye S，Xiong C，et al.Successful treatment with bortezomib and thalidomide for POEMS syndrome associated with multicentric mixed-type Castleman's disease［J］.Jpn J Clin Oncol，2011，41(10)：1221-1224.
［17］Li J，Zhang W，Kang WY，et al.Bortezomib and dexamethasone as first-line therapy for a patient with newly diagnosed polyneuropathy，organomegaly，endocrinopathy，M protein and skin changes syndrome complicated by renal failure［J］.Leuk Lymphoma，2012，53(12)：2527-2529.
［18］Zeng Ke,Liu Zhigang,Yang Quanrong,et al.Bottezomib subcutaneous injection combined with autologous hematopoietic stem cell transplantation for poems syndrome: a case report and literature review［J］.Chin J Hematol,2013,34(6):550-552.
［19］Takehito Iwase，Hirotaka Yokouch，Sonoko Misawa，et al.Reduction of optic disc oedema by bortezomib and dexamethasone followed by autologous peripheral blood stem cell transplantation in patient with POEMS syndrome［J］.Neuro-ophthalmology，2018，42(1)：25-30.
［20］Yoshimi Ishii，Etsuko Yamazaki，Yasufumi Ishiyama,et al.Successful treatment of POEMS syndrome with bortezomib and dexamethasone，combined with radiotherapy，and followed by autologous stem cell transplantation［J］.Int J Hematol，2013，98(6)：723-728.
［21］Argyriou AA，Iconomou G，Kalofonos HP.Bortezomib-induced peripheral neuropathy in multiple myeloma：A comprehensive review of the literature［J］.Blood，2008，112(5)：1593-1599.
［22］Bringhen S，Larocca A，Rossi D，et al.Efficacy and safety of once-weekly bortezomib in multiple myeloma patients［J］.Blood，2010，116(23)：4745-4753.
［23］Moreau P，Coiteux V，Hulin C，et al.Prospective comparison of subcutaneous versus intravenous administration of bortezomib in patients with multiple myeloma［J］.Haematologica，2008，93(12)：1908-1911.